We represented a developer of consumer and commercial products in connection with building a portfolio of patents and other intellectual property assets, IP strategy, commercializing its technology, and licensing matters. We represented the client in connection with a research and development agreement with a public university system to develop applications of NASA technology in consumer and healthcare products. We also represented the client in negotiating a technology transfer/patent license agreement with a public university system.
Strategic IP Counseling for an Early Stage Technology Company
Client Type: Private Company
You Also May Be Interested In:
-
Lead Counsel to POINT Biopharma Inc. in its SPAC Business Combination with Research Alliance Corp. I
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
-
Represented Boston Children’s Hospital with intellectual property, business, and government contracting issues associated with VaccineFinder
-
We represented Tractor Supply Company (Nasdaq: TSCO) in their agreement to acquire Orscheln Farm and Home, a family-owned farm and ranch retailer.